Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adrenal medullary tissue
attention deficit disorder with hyperactivity
basal ganglia
basal ganglia, lesion of
brain transplantation
catecholamine
cerebral ischemia
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
dementia
dopamine
dystonia musculorum deformens
gamma amino butyric acid
genetic neurologic disorders
Gilles de la Tourette syndrome
Gulf War syndrome
hepatic encephalopathy
hepatic encephalopathy, treatment of
homovanillic acid
hydroxyindole acetic acid 5(5HIAA)
L-dopa
monoamines
MRS
multiple sclerosis
neuropathology
neurotransmitter
norepinephrine
Parkinson disease
Parkinson disease, juvenile
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
phenylketonuria
Riley-Day syndrome
seizure
serotonin
tardive dyskinesia
torticollis
trauma
treatment of neurologic disorder
varicella zoster virus
varicella zoster virus, encephalitis
vasospasm, cerebral
Showing articles 500 to 550 of 1154 << Previous Next >>

Clinicopath Conf., Colchicine Myoneuropathy
NEJM 349:1656-1663, Case 33-2003, 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Intrathecal Baclofen Withdrawal Mimicking Sepsis
J Emerg Med 24:423-427, Kao,L.W.,e tal, 2003

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

Laughing Headache: A Novel Type of Triggered Headache with Response to Divalproex Sodium
Headache 43:801-803, Levin,M. &Ward,T.N., 2003

Mutations in the Molybdenum Cofactor Biosynthetic Genes MOCS1, MOCS2, and GEPH
Hum Mutat 21:569-576, Reiss,J. &Johnson,J.L., 2003

Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003

Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003

Asymptomatic Microbleeds as a Risk Factor for Aspirin-Associated Intracerebral Hemorrhages
Neurol 60:511-513, Wong,K.S.,et al, 2003

Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003

Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia
NEJM 346:457, Sabra,C.,et al, 2002

Symptoms of B12 Deficiency Can Occur in Women of Child Bearing Age Supplemented with Folate
Neurol 58:1572-1573, Drazkowski,J.,et al, 2002

Dietary Intake of Folate and Risk of Stroke in US Men and Women
Stroke 33:1183-1189, Bazzano,L.A.,et al, 2002

Prognostic Significance of Uric Acid Serum Concentration in Patients with Acute Ischemic Stroke
Stroke 33:1048-1052, Chamorro,A.,et al, 2002

Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002

A Randomized Trial of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis
Neurol 58:1652-1659, Freitag,F.G.,et al, 2002

Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002

Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002

Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002

MR Changes after Acute Cyanide Intoxication
AJNR 23:1398-1401, Rachinger,J.,et al, 2002

Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002

New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002

Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002

Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002

Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002

Transient Ischemic Attack
NEJM 347:1687-1692, Johnston,S.C., 2002

Glutamic Acid Decarboxylase Autoantibodies and Neurological Disorders
Neurol Sci 23:145-151, Vianello,M.,et al, 2002

A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002

Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies
Arch Neurol 58:225-230, Honorat,J.,et al, 2001

Intake of Fish and Omega-3 Fatty Acids and Risk of Stroke in Women
JAMA 285:304-312, Iso,H.,et al, 2001

Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001

Use of Aspirin, Epistaxis, and Untreated Hypertension as Risk Factors for Primary Intracerebral Hemorrhage in Middle-Aged and Elderly People
Stroke 32:399-404, Saloheimo,P.,et al, 2001

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001

Baclofen Treatment in Tourette Syndrome
Neurol 56:599-604, Singer,H.S.,et al, 2001

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies
Neurol 56:814, Marchiori,G.C.,et al, 2001

Rescue Treatment with Abciximab in Acute Ischemic Stroke
Neurol 56:1585-1587, Lee,K.Y.,et al, 2001

Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube Defects
JAMA 285:2981-2986,3022, Honein,M.A.,et al, 2001

Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA 286:78-82, Akkerhuis,K.M.,et al, 2001

Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency
Arch Int Med 161:1534-1541, Hvas,A.,et al, 2001

Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes Without St-Segment Elevation
NEJM 345:494-502, The Clopidogrel in Unstable Angina to Prevent Recu, 2001

Tinzaparin in Acute Ischaemic Stroke (TAIST):A Randomised Aspirin-Controlled Trial
Lancet 358:702-710,683, Bath,P.M.W.,et al, 2001

Risk Factors for Visual Loss in Giant Cell (Temporal) Arteritis:A Prospective Study of 174 Patients
Am J Med 111:211-217, Liozohn,E.,et al, 2001

A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001

Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001

Combination Therapy With Clopidogrel and Aspirin
Stroke 32:2948-2949, Albers,G.W. &Amerenco,P., 2001



Showing articles 500 to 550 of 1154 << Previous Next >>